°øÁö»çÇ×

    • home
    • °øÁö»çÇ×

°øÁö»çÇ×

ÇкÎÀÎÅÏ, ´ëÇпø»ý ¹× Æ÷½º´Ú ¿¬±¸¿ø °ø°í (NextGen Medicine Lab, ÀÇ°ú´ëÇÐ/ÀΰøÁö´ÉÇаú/»ï¼º¼­¿ïº´¿ø)

  • ÀÇ°ú´ëÇÐÇàÁ¤½Ç
  • Á¶È¸¼ö 2449
  • 2022-01-20 ¿ÀÈÄ 1:01:09
Á¦¸ñ¾øÀ½

¼º±Õ°ü´ë ÀÇ°ú´ëÇÐ/ÀΰøÁö´ÉÇаú/»ï¼º¼­¿ïº´¿ø NextGen Medicine Lab¿¡¼­ Çкבּ¸ÀÎÅÏ, ´ëÇпø»ý ¹× Æ÷½º´Ú ¿¬±¸¿øÀ» ¸ðÁýÇÕ´Ï´Ù. 


º» ¿¬±¸½ÇÀº »ï¼º¹Ì·¡±â¼úÀ°¼º°úÁ¦ ¹× °úÇбâ¼úºÎ ¿¬±¸Áö¿øÀ» ¹Þ¾Æ,

ÀΰøÁö´É/µ¥ÀÌÅÍ »çÀ̾𽺸¦ ¹ÙÅÁÀ¸·Î ¾Ï À¯ÀüÀÚ µ¥ÀÌÅ͸¦ ºÐ¼®ÇÔÀ¸·Î½á,

¾Ï Á¤¹ÐÀÇÇÐ ±¸Çö°ú Ç×¾Ï ½Å¾à °³¹ß¿¡ ¸ÅÁøÇÏ°í ÀÖ½À´Ï´Ù. 


°ü½ÉÀÖ´Â ¿©·¯ºÐÀÇ ¸¹Àº Áö¿ø ¹Ù¶ø´Ï´Ù.

¿¬¶ôó: joosang.lee@skku.edu(ÀÇ°ú´ëÇÐ ÀÌÁÖ»ó ±³¼ö)


ÇкÎÀÎÅÏ/´ëÇпø»ý: https://www.ibric.org/myboard/read.php?Board=job_recruit&id=652525

Æ÷½º´Ú/¿¬±¸±³¼ö: https://www.ibric.org/myboard/read.php?Board=job_recruit&id=646460

¿¬±¸½Ç ȨÆäÀÌÁö: https://leejoosang.wixsite.com/ngml


ÃÖ±Ù³í¹®:

S Sinha,..., JS Lee#, et al. A systematic genome-wide mapping of oncogenic mutation selection during CRISPR-Cas9 genome editing. Nature Communications (2021).

JS Lee#, et al. Synthetic lethality mediated precision oncology via the tumor transcriptome. Cell (2021).

R Keshet*, JS Lee*, et al. T argeting purine synthesis in ASS1-expressing tumors enhances the response to immune checkpoint inhibitors. Nature Cancer (2020).

S Kalaora*, JS Lee*, et al. Immunoproteasome expression is associated with better prognosis and response to checkpoint therapies in melanoma. Nature Communications (2020).

G Pathria, JS Lee, et al. Translational reprogramming marks adaptation to asparagine restriction in cancer. Nature Cell Biology (2019).

JS Lee#, E Ruppin#. Multiomics prediction of response rates to therapies to inhibit programmed cell death 1 and programmed cell death 1 ligand 1, JAMA Oncology (2019).

X Feng, N Arang, DC Rigiracciolo, JS Lee#, et al. A platform of synthetic lethal gene interaction networks reveals that the GNAQ uveal melanoma oncogene controls the Hippo pathway through FAK. Cancer Cell (2019).

AD Sahu*, JS Lee*, et al.Genome‐wide prediction of synthetic rescue mediators of resistance to targeted and immunotherapy. Molecular Systems Biology (2019).

N Auslander, G Zhang, JS Lee, et al.. Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma. Nature Medicine (2018).

JS Lee*, L Adler*, et al. Urea cycle dysregulation generates clinically relevant genomic and biochemical signatures. Cell (2018). (±¹¹ÎÀϺ¸: http://news.kmib.co.kr/article/view.asp?arcid=0924023237)

JS Lee*, A Das*, et al. Harnessing synthetic lethality to predict the response to cancer treatment. Nature Communications (2018).